作者
Suzanne L. Topalian,F. Stephen Hodi,Julie R. Brahmer,Scott Gettinger,David C. Smith,David F. McDermott,John D. Powderly,Richard D. Carvajal,Jeffrey A. Sosman,Michael B. Atkins,Philip D. Leming,David R. Spigel,Scott Antonia,Leora Horn,Charles G. Drake,Drew M. Pardoll,Lieping Chen,William H. Sharfman,Robert A. Anders,Janis M. Taube,Tracee L. McMiller,Haiying Xu,Alan J. Korman,Maria Jure–Kunkel,Shruti Agrawal,D. G. McDonald,Georgia Kollia,Ashok Gupta,Jon M. Wigginton,Mario Sznol
摘要
Blockade of programmed death 1 (PD-1), an inhibitory receptor expressed by T cells, can overcome immune resistance. We assessed the antitumor activity and safety of BMS-936558, an antibody that specifically blocks PD-1.
JY
寻道图强
lin
Cloud
CipherSage
穆紫
美好乐松
凤凰
星辰大海
温暖的盼山
YifanWang
hzc
黑白
jyy
脑洞疼
Simon
结实的寄柔
Singularity
可爱的函函
科目三
皖公网安备34019202002308
